Compare CVS Health Corp (CVS) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Simon Property Group Inc — how do they compare? CVS Health Corp trades at $86.27 (market cap $112.29B), while Simon Property Group Inc trades at $199.3 (market cap $64.59B). The key difference: CVS Health Corp is the larger of the two by market cap, and Simon Property Group Inc pays the higher dividend (4.46%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Simon Property Group Inc for 99 Days on average.
| CVS | SPG | |
|---|---|---|
Market Cap | $112.29B | $64.59B |
Volume | 7,763,676 | 1,093,907 |
Sector | Health | Real Estate |
52-Week High | $110.60 | $236.70 |
52-Week Low | $70.08 | $173.35 |
Typical Hold Time | 83 Days | 99 Days |
Enterprise Value | $174.64B | $93.03B |
Dividend Yield | 3.03% | 4.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
Simon Property Group (SPG) trades at $197.59, down 2.06% amid bearish technical signals, though fundamentals remain strong with robust profitability margins (net income margin 66.57%) and consistent revenue growth. Recent Q2 2026 earnings missed expectations, but Q4 2025 and Q1 2026 beat estimates. The company maintains solid cash flow from operations ($4.14B in 2025) and a raised dividend, while facing headwinds from rising bond yields and debt maturities.
Outlook: SPG offers value with a P/E of 14.09 below sector averages and a 42% analyst buy rating, targeting 13% upside to consensus. Risks include interest rate sensitivity, high leverage ($24.21B debt), and retail sector volatility. The stock's current pullback may present a buying opportunity for income investors, supported by strong leasing demand and strategic initiatives like the Simon Media Network launch.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
